Terms: = Germ cell tumor AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Prognosis
12 results:
1. Novel insight into histological and molecular astrocytoma, IDH-mutant, Grade 4 by the updated WHO classification of central nervous system tumors.
Chen W; Guo S; Wang Y; Shi Y; Guo X; Liu D; Li Y; Wang Y; Xing H; Xia Y; Li J; Wu J; Liang T; Wang H; Liu Q; Jin S; Qu T; Li H; Yang T; Zhang K; Wang Y; Ma W
Cancer Med; 2023 Sep; 12(18):18666-18678. PubMed ID: 37667984
[TBL] [Abstract] [Full Text] [Related]
2. GDPD5 Related to Lipid Metabolism Is a Potential Prognostic Biomarker in Neuroblastoma.
Luo T; Peng J; Li Q; Zhang Y; Huang Y; Xu L; Yang G; Tan D; Zhang Q; Tan Y
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430219
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-germ cell Neoplasms: Report of 2 Cases and Review of Literature.
Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
[TBL] [Abstract] [Full Text] [Related]
4. [Diffuse midline gliomas with H3K27 alteration in children: a clinicopathological analysis of forty-one cases].
Li J; Ma YY; Feng J; Zhao D; Ding F; Tian L; Chen R; Zhao R
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):319-325. PubMed ID: 35359043
[No Abstract] [Full Text] [Related]
5. Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.
Saeed MEM; Kadioglu O; Greten HJ; Yildirim A; Mayr K; Wenz F; Giordano FA; Efferth T
Invest New Drugs; 2021 Jun; 39(3):670-685. PubMed ID: 33313992
[TBL] [Abstract] [Full Text] [Related]
6. Comparative proteogenomic characterization of glioblastoma.
Asif S; Fatima R; Krc R; Bennett J; Raza S
CNS Oncol; 2019 Jun; 8(2):CNS37. PubMed ID: 31290679
[No Abstract] [Full Text] [Related]
7. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract] [Full Text] [Related]
8. Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas.
Shi ZF; Li KK; Kwan JSH; Yang RR; Aibaidula A; Tang Q; Bao Y; Mao Y; Chen H; Ng HK
Brain Pathol; 2019 Nov; 29(6):782-792. PubMed ID: 30861589
[TBL] [Abstract] [Full Text] [Related]
9. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract] [Full Text] [Related]
10. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract] [Full Text] [Related]
11. MicroRNA-542-3p Suppresses tumor cell Invasion via Targeting AKT Pathway in Human Astrocytoma.
Cai J; Zhao J; Zhang N; Xu X; Li R; Yi Y; Fang L; Zhang L; Li M; Wu J; Zhang H
J Biol Chem; 2015 Oct; 290(41):24678-88. PubMed ID: 26286747
[TBL] [Abstract] [Full Text] [Related]
12. Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.
Fransson S; Abel F; Kogner P; Martinsson T; Ejeskär K
Int J Oncol; 2013 Feb; 42(2):609-16. PubMed ID: 23232578
[TBL] [Abstract] [Full Text] [Related]
